Charles Schwab Investment Management Inc Pulmonx Corp Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 315,532 shares of LUNG stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

315,532

Previous 313,169 0.75%

Holding current value

$2.15 Million

Previous $2.6 Million 17.49%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$5.93 - $7.71 $14,012 - $18,218	2,363 Added 0.75%	315,532 $2.14 Million
Q3 2024 Nov 12, 2024	BUY	$5.59 - $8.58 $86,885 - $133,358	15,543 Added 5.22%	313,169 $2.6 Million
Q2 2024 Aug 12, 2024	SELL	$5.77 - $9.82 $21,614 - $36,785	-3,746 Reduced 1.24%	297,626 $1.89 Million
Q1 2024 May 08, 2024	BUY	$8.71 - $14.65 $104,650 - $176,019	12,015 Added 4.15%	301,372 $2.79 Million
Q4 2023 Feb 06, 2024	BUY	$7.89 - $13.14 $33,729 - $56,173	4,275 Added 1.5%	289,357 $3.69 Million
Q3 2023 Nov 08, 2023	BUY	$9.88 - $14.0 $80,848 - $114,562	8,183 Added 2.96%	285,082 $2.94 Million
Q2 2023 Aug 09, 2023	BUY	$10.78 - $13.65 $91,382 - $115,711	8,477 Added 3.16%	276,899 $3.63 Million
Q1 2023 May 11, 2023	BUY	$7.49 - $12.54 $139,209 - $233,068	18,586 Added 7.44%	268,422 $3 Million
Q4 2022 Feb 13, 2023	SELL	$4.92 - $17.35 $59,827 - $210,976	-12,160 Reduced 4.64%	249,836 $2.11 Million
Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $199,764 - $312,205	13,014 Added 5.23%	261,996 $4.37 Million
Q2 2022 Aug 15, 2022	BUY	$14.0 - $27.95 $212,744 - $424,728	15,196 Added 6.5%	248,982 $3.67 Million
Q1 2022 May 13, 2022	BUY	$21.13 - $35.65 $117,208 - $197,750	5,547 Added 2.43%	233,786 $5.8 Million
Q4 2021 Feb 11, 2022	BUY	$29.72 - $45.1 $189,405 - $287,422	6,373 Added 2.87%	228,239 $7.32 Million
Q3 2021 Nov 16, 2021	BUY	$35.98 - $44.48 $4.24 Million - $5.24 Million	117,710 Added 113.01%	221,866 $7.98 Million
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $1.18 Million - $1.51 Million	31,424 Added 43.21%	104,156 $4.6 Million
Q1 2021 May 17, 2021	BUY	$44.0 - $67.54 $74,404 - $114,210	1,691 Added 2.38%	72,732 $3.33 Million
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $2.79 Million - $4.9 Million	71,041 New	71,041 $4.9 Million

Others Institutions Holding LUNG

# of Institutions

131

Shares Held

31.4M

Call Options Held

500

Put Options Held

213K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $254M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Pulmonx Corp Transaction History